No Association between Obesity and Behavior in Low-income, Preschool Latino Children

Insights

This study found no link between behavioral issues and obesity in three-year-old Latino children. Early childhood obesity in this demographic may not be related to behavioral problems.

Area of Science:

  • Pediatrics
  • Child Psychology
  • Public Health

Background:

  • The connection between behavioral problems and early childhood obesity in Latino populations remains understudied.
  • Understanding this relationship is crucial for targeted public health interventions.

Purpose of the Study:

  • To investigate the association between behavioral problems and obesity in three-year-old children of Latina mothers.
  • To address a gap in the literature regarding Latino children's health.

Main Methods:

  • A cross-sectional study analyzed anthropometric and behavioral data from 174 three-year-old children.
  • Behavioral data were collected using the preschool Child Behavior Checklist (CBCL/1½-5).
  • Logistic regression models were employed to assess the association between behavioral problems and obesity.

Main Results:

  • Obesity prevalence was 27.7% among three-year-old children in the study sample.
  • No statistically significant associations were found between obesity and specific behavioral problems including affective, anxiety, pervasive developmental, attention deficit hyperactivity, or oppositional defiant disorders.
  • Confidence intervals for all behavioral problem categories included one, indicating no significant link to obesity.

Conclusions:

  • Contrary to findings in older populations, no association was observed between psychological problems and obesity in this cohort of low-income, three-year-old Latino children.
  • These findings suggest that the relationship between behavioral issues and obesity may develop later in childhood or adolescence.
  • Further research is needed to explore potential developmental trajectories of this relationship.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.6K
Causes of Social Behavior III: Biological and Environmental Influences01:28

Causes of Social Behavior III: Biological and Environmental Influences

Social behavior is a complex phenomenon that arises from the interaction between biological predispositions and environmental influences. This intricate interplay shapes how individuals think, feel, and act in various social contexts. Understanding these mechanisms requires insights from psychology, neuroscience, genetics, and evolutionary theory.Environmental Influences on Social BehaviorEnvironmental factors, including temperature, odors, and visual stimuli, play a crucial role in shaping...
462
Conduct Disorder01:28

Conduct Disorder

Conduct disorder is a complex mental health diagnosis characterized by a repetitive and persistent pattern of behavior that violates societal norms, the rights of others, or age-appropriate rules. The diagnostic criteria for conduct disorder require the presence of at least three problematic behaviors within the past 12 months, with at least one occurring in the past six months. These behaviors are grouped into four categories: aggression toward people and animals; destruction of property;...
936
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
306
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
404
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
349